Literature DB >> 17005471

Testicular neoplasms. Evaluation of the experience during 25 years in a military hospital.

Ramón Diz-Rodríguez1, Miguel Vírseda-Chamorro, Pedro Paños-Lozano, Antonio Colmenarejo Rubio, Ignacio Arance-Gil, Ana Moreno Posadas.   

Abstract

INTRODUCTION: Testicular tumors are frequent in young adults, coinciding with incorporation to military service. The present study evaluates the tumor characteristics, time course and results obtained with the treatments used in our center for this type of neoplasms.
MATERIAL AND METHODS: A retrospective longitudinal study was conducted in a cohort of 98 patients with an average age of 28.6 years, subjected to orchiectomy for testicular tumors in our center between 1979 and 2004. Data were collected relating to patient age, tumor characteristics, the outcome of treatment, and the course of the disease.
RESULTS: The right testicle was affected in 61% (with significant differences versus the left side). The most common histological type corresponded to non-seminomatous germ cell tumors (NSGCTs) (65.3%), followed by pure seminomas (27.6%) and non-germinal cell tumors (NGCs) (7.1%). NSGCT was diagnosed at a significantly younger average age (23.2 years) than the other two tumor types. Stage I was the most frequent presentation (58%). Seminomas presented in stage I significantly more often (80%) than the others tumors. The data collected over the 25-year study period showed no significant variations in tumor characteristics. The log-rank test showed a significant difference in terms of patient survival according to the tumor cell line (p = 0.000) and stage (p = 0.000), except between stages I and II, where no significant differences were observed in terms of survival.
CONCLUSIONS: Non-seminomatous germ cell tumors (NSGCTs) are the most frequent testicular tumors in young adults. Most neoplasms are diagnosed in early stages, the prognosis being better in the case of seminomas and tumor stages I and II.

Entities:  

Mesh:

Year:  2006        PMID: 17005471     DOI: 10.1007/s12094-006-0039-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  28 in total

1.  Testes tumors in a Sub-Saharan African city (Yaounde). Incident cases and histopathology.

Authors:  F F Angwafo; S Takongmo; A Mbakop; V A Ngu
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

2.  Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG).

Authors:  J R Germà-Lluch; X Garcia del Muro; P Maroto; L Paz-Ares; J A Arranz; J Gumà; E Alba; J Sastre; J Aparicio; A Fernández; A Barnadas; J Terrassa; A Sáenz; D Almenar; M López-Brea; M A Climent; M A Sánchez; R Lasso de la Vega; G Berenguer; X Pérez
Journal:  Eur Urol       Date:  2002-12       Impact factor: 20.096

Review 3.  [Testicular tumors: our experience].

Authors:  M Soto Delgado; C Varo Solís; A Juárez Soto; J Bachiller Burgos; V Beltrán Aguilar; D González Moreno; C Sánchez Bernal
Journal:  Arch Esp Urol       Date:  1999-03       Impact factor: 0.436

4.  Clinical study of testicular germ cell tumors.

Authors:  H Tomomasa; H Shimizu; S Sato; Y Adachi; Y Ashizawa; Y Kamiyama; Y Okano; M Sato; T Yoshii; T Iizumi; T Umeda; T Yazaki
Journal:  Hinyokika Kiyo       Date:  2001-06

5.  Decreased survival of black Americans with testicular cancer.

Authors:  P J Bridges; R Sharifi; A Razzaq; P Guinan
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

Review 6.  Increasing incidence of testicular cancer worldwide: a review.

Authors:  Eric Huyghe; Tomohiro Matsuda; Patrick Thonneau
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

Review 7.  [Leydig cell tumor: report of 8 cases and review of the literature].

Authors:  G Cruceyra Betriu; A Tejido Sánchez; J M Duarte Ojeda; J P García De La Torre; J M De La Morena Gallego; V Martínez Silva; O Leiva Galvis
Journal:  Actas Urol Esp       Date:  2002-01       Impact factor: 0.994

8.  Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.

Authors:  P Warde; M K Gospodarowicz; D Banerjee; T Panzarella; L Sugar; C N Catton; J F Sturgeon; M Moore; M A Jewett
Journal:  J Urol       Date:  1997-05       Impact factor: 7.450

9.  A case of testicular rhabdomyosarcoma.

Authors:  M Erkan Erbay; Fatih Tarhan; Nagehan Ozdemir Barişik; Uğur Kuyumcuoğlu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

10.  Trends in the incidence of testicular germ cell tumors in the United States.

Authors:  Katherine A McGlynn; Susan S Devesa; Alice J Sigurdson; Linda M Brown; Lilian Tsao; Robert E Tarone
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

View more
  1 in total

1.  Higher frequency of thyroid tumors in the right lobe.

Authors:  Alois Gessl; Wolfgang Raber; Anton Staudenherz; Alexander Becherer; Oskar Koperek; Andrea Hofmann
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.